← Back to Screener
Absci Corporation Common Stock (ABSI)
Price$3.95
Favorite Metrics
Price vs S&P 500 (26W)-11.46%
Price vs S&P 500 (4W)11.45%
Market Capitalization$547.82M
All Metrics
Book Value / Share (Quarterly)$1.25
P/TBV (Annual)3.55x
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)-21.33%
Cash Flow / Share (Quarterly)$-0.62
Price vs S&P 500 (YTD)-1.56%
Net Profit Margin (TTM)-4113.68%
EPS (TTM)$-0.85
10-Day Avg Trading Volume3.71M
EPS Excl Extra (TTM)$-0.85
Revenue Growth (5Y)-10.14%
EPS (Annual)$-0.84
ROI (Annual)-60.52%
Net Profit Margin (5Y Avg)-2451.57%
Cash / Share (Quarterly)$0.95
Revenue Growth QoQ (YoY)-2.26%
ROA (Last FY)-53.25%
Revenue Growth TTM (YoY)-38.24%
EBITD / Share (TTM)$-0.76
ROE (5Y Avg)-49.39%
Operating Margin (TTM)-4297.04%
Cash Flow / Share (Annual)$-0.62
P/B Ratio2.89x
P/B Ratio (Quarterly)2.77x
Net Income / Employee (Annual)$-1
EV / Revenue (TTM)188.81x
Net Interest Coverage (TTM)-549.78x
ROA (TTM)-50.99%
EPS Incl Extra (Annual)$-0.84
Current Ratio (Annual)6.57x
Quick Ratio (Quarterly)6.34x
3-Month Avg Trading Volume3.62M
52-Week Price Return17.38%
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$0.98
P/S Ratio (Annual)195.65x
Asset Turnover (Annual)0.01x
52-Week High$5.23
Operating Margin (5Y Avg)-2431.34%
EPS Excl Extra (Annual)$-0.84
CapEx CAGR (5Y)-12.68%
26-Week Price Return-2.72%
Quick Ratio (Annual)6.34x
13-Week Price Return6.87%
Total Debt / Equity (Annual)0.00x
Current Ratio (Quarterly)6.57x
Enterprise Value$528.664
Revenue / Share Growth (5Y)-17.27%
Asset Turnover (TTM)0.01x
Revenue / Employee (Annual)$0
Pretax Margin (Annual)-4111.21%
Cash / Share (Annual)$0.95
3-Month Return Std Dev83.62%
Net Income / Employee (TTM)$-1
ROE (Last FY)-60.80%
Net Interest Coverage (Annual)-549.78x
EPS Basic Excl Extra (Annual)$-0.84
Receivables Turnover (TTM)13.74x
Total Debt / Equity (Quarterly)0.00x
EPS Incl Extra (TTM)$-0.85
Receivables Turnover (Annual)3.86x
ROI (TTM)-59.10%
P/S Ratio (TTM)195.65x
Pretax Margin (5Y Avg)-2489.30%
Revenue / Share (Annual)$0.02
Tangible BV / Share (Annual)$0.98
Price vs S&P 500 (52W)-17.72%
Year-to-Date Return2.58%
5-Day Price Return17.38%
EPS Normalized (Annual)$-0.84
ROA (5Y Avg)-41.75%
Net Profit Margin (Annual)-4113.68%
Month-to-Date Return19.33%
Cash Flow / Share (TTM)$-1.01
EBITD / Share (Annual)$-0.75
Operating Margin (Annual)-4297.04%
LT Debt / Equity (Annual)0.00x
ROI (5Y Avg)-47.98%
LT Debt / Equity (Quarterly)0.00x
EPS Basic Excl Extra (TTM)$-0.85
P/TBV (Quarterly)3.55x
P/B Ratio (Annual)2.77x
Pretax Margin (TTM)-4111.21%
Book Value / Share (Annual)$1.25
Price vs S&P 500 (13W)4.00%
Beta2.03x
Revenue / Share (TTM)$0.02
ROE (TTM)-59.68%
52-Week Low$2.24
Analyst Recommendations
Jan 2026
Feb 2026
Mar 2026
Apr 2026
4.13
4.07
4.07
4.07
Industry Peers — R&D — Physical Sciences(9)
| Symbol | P/E Ratio (Annual) | ROE (TTM) | Revenue Growth (5Y) | Indicated Dividend Yield (Annual) | Price |
|---|---|---|---|---|---|
ABSIAbsci Corporation Common Stock | — | -59.68% | -10.14% | — | $3.95 |
IQVIQVIA Holdings Inc. | 22.06x | 22.28% | 7.50% | — | $176.76 |
INCYIncyte Genomics Inc | 15.00x | 29.15% | 14.03% | — | $96.92 |
MEDPMedpace Holdings, Inc. Common Stock | 32.96x | 118.82% | 22.27% | — | $528.44 |
CRLCharles River Laboratories International, Inc. | — | -4.40% | 6.55% | — | $185.54 |
NRCNational Research Corporation Common Stock (Delaware) | 35.35x | 58.51% | 0.61% | 3.55% | $18.18 |
OABIOmniAb, Inc. Common Stock | — | -23.99% | -4.31% | — | $1.55 |
MXCTMaxCyte, Inc. Common Stock | — | -24.06% | 4.76% | — | $0.86 |
NOTVInotiv, Inc. Common Stock | — | -50.77% | 53.35% | — | $0.29 |
ISPCiSpecimen Inc. Common Stock | — | -496.37% | -25.09% | — | $0.13 |
About
Absci Corp is an AI-powered synthetic biology company focused on developing novel protein therapeutics. Its integrated platform unifies biologic drug discovery and cell line development, enabling faster creation of next-generation biologics.